Skip to main content
. 2005 Oct 26;92(5):650–657. doi: 10.1136/hrt.2005.070698

Table 2 Angiographic parameters for studies with sirolimus eluting stents.

Study Indications for PCI Mean RVD (mm) Mean lesion length (mm) Target artery (%) ACC/AHA class (%) Multivessel disease (%) Previous MI (%) AP (%)
LAD RCA LCX A B1 B2 C Stable Unstable
Sirolimus trials
SIRIUS (2003)4 Stable or unstable AP, signs of myocardial ischaemia 2.80 14.40 44 31 25 8 36 33 23 42 31 58 53
E‐SIRIUS (2003)1 Stable or unstable AP, silent ischaemia 2.55 15.00 56 21 23 NA NA NA NA 36 42 NA 33
C‐SIRIUS (2004)3 Stable or unstable AP, silent ischaemia 2.63 13.60 36 41 23 NA NA 59 40 42 12 51
DIABETES (2005)30 Symptoms or objective evidence of ischaemia 2.34 15.00 41 37 22 NA NA 80 65 37 NA NA
RAVEL (2002)2 Stable or unstable AP, silent ischaemia 2.62 9.58 50 27 23 6 37 57 0 NA 36 39 50
SES‐SMART (2004)8 ACS, stable AP, silent myocardial ischaemia as shown by exercise stress test 2.20 11.84 28 16 30 25 47 24 4 65 NA NA NA
Paclitaxel trials
TAXUS I (2003)5 Stable or unstable AP or silent ischaemia 2.97 11.30 40 30 30 23 41 36 0 NA 28 NA NA
TAXUS II (2003)6, 32, 33 Stable or unstable AP or silent ischaemia 2.75 10.48 45 36 19 NA NA NA NA NA 40 60 34
TAXUS IV (2004)7, 29 Stable or unstable angina or provokable ischaemia 2.75 13.40 41 31 28 NA NA NA NA NA 30 NA 34
TAXUS VI (2005)31 Stable or unstable AP or silent ischaemia 2.78 20.62 NA NA 28 56 NA NA NA NA

ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; AP, angina pectoris; LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; MI, myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; RVD, reference vessel diameter.